Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 387

Results For "MS"

5474 News Found

World BioProtection Forum India & Sharda University to host World BioProtection Summit – India 2022
Biotech | September 09, 2022

World BioProtection Forum India & Sharda University to host World BioProtection Summit – India 2022

Two main objectives are: Accelerate novel technologies and products for global markets; and Connect academia and industry, creating synergy for faster advancement of the Bioprotection sector


Healthcare sector is expected to reach US $50 bn by 2025
News | September 08, 2022

Healthcare sector is expected to reach US $50 bn by 2025

Healthcare has become more focused on innovation and technology over the past two years and 80% of healthcare systems are aiming to increase their investment in digital healthcare tools in the coming five years


Honeywell to collaborate with leading health providers to advance digitalization of healthcare globally
Digitisation | September 08, 2022

Honeywell to collaborate with leading health providers to advance digitalization of healthcare globally

Aimed at improving patient outcomes and increasing connectivity for more efficient monitoring In hospitals and homes


Health Secretary addresses workshop on 'Roadmap to Strengthen Public Health Preparedness and Response Capabilities of Points of Entry (PoEs) in India'
Policy | September 08, 2022

Health Secretary addresses workshop on 'Roadmap to Strengthen Public Health Preparedness and Response Capabilities of Points of Entry (PoEs) in India'

India is an example in front of the world to contribute towards strengthening Points of Entry during a public health emergency


President to launch Pradhan Mantri TB Mukt Bharat Abhiyaan on Sept 9
Policy | September 08, 2022

President to launch Pradhan Mantri TB Mukt Bharat Abhiyaan on Sept 9

The virtual event will be attended by representatives from state & district health administration, corporates, industries, civil society, and NGOs as the country reiterates its commitment towards TB elimination by 2025


Cipla receives US FDA approval for Revlimid (Lenalidomide) capsules
Drug Approval | September 08, 2022

Cipla receives US FDA approval for Revlimid (Lenalidomide) capsules

Depending on the type of cancer, it can be used as monotherapy or combination as a part of first line regimen, maintenance regimen or relapsed settings


SIRIO appoints Lonza’s Sara Lesina as General Manager in Europe
People | September 08, 2022

SIRIO appoints Lonza’s Sara Lesina as General Manager in Europe

Her appointment further strengthens the CDMO’s strategy to become the nutraceutical R&D hub for brands looking for agile partners with large scientific and development resources


Lonza and Touchlight collaborate on end-to-end mRNA offering
Biotech | September 07, 2022

Lonza and Touchlight collaborate on end-to-end mRNA offering

Under the terms of the agreement, Lonza can now provide its customers with seamless access to Touchlight’s enzymatic DNA technology


World’s first intra nasal vaccine iNCOVACC from Bharat Biotech receives approval
Drug Approval | September 07, 2022

World’s first intra nasal vaccine iNCOVACC from Bharat Biotech receives approval

iNCOVACC was developed in partnership with Washington University St. Louis, which had designed and developed the recombinant adenoviral vectored constructs and evaluated them in preclinical studies for efficacy


Football sized rare mesenteric tumour removed laparoscopically at the CK Birla Hospital
News | September 07, 2022

Football sized rare mesenteric tumour removed laparoscopically at the CK Birla Hospital

In a rare occurrence worldwide, the CK Birla Hospital® treats 32-year-old woman for a giant mesenteric tumour via complex laparoscopic surgery